Copyright (c) 2006 Cancer Consultants. All rights reserved.Professional Cancer News from all disease categories.http://rss.cancerconsultants.com/ProFeed.aspx60http://professional.cancerconsultants.com/news.aspx?id=44311http://professional.cancerconsultants.com/news.aspx?id=44311Researchers from France have reported encouraging results with adding Velcade® (bortezomib) to high-dose melphalan followed by autologus stem cell infusion for initial treatment of patients with newly diagnosed multiple myeloma. The details of this Phase II study appeared in an early online publication in Blood on November 2, 2009.jmaxon@onco-ed.com (jenny maxon)Fri, 20 Nov 2009 12:21:41 GMThttp://professional.cancerconsultants.com/news.aspx?id=44310http://professional.cancerconsultants.com/news.aspx?id=44310Researchers affiliated with the Health Professional Follow-Up Study and the Nurses’ Health Study have reported that folic acid supplementation in patients with recurrent colorectal adenoma was not protective or harmful in most patients. However, patients who were folate deficient had a significant 39% decrease in adenoma recurrence. The details of this study appeared in an early online publication on October 28, 2009 in the American Journal of Clinical Nutrition.jmaxon@onco-ed.com (jenny maxon)Fri, 20 Nov 2009 12:01:36 GMThttp://professional.cancerconsultants.com/news.aspx?id=44309http://professional.cancerconsultants.com/news.aspx?id=44309Researchers from the University of Pennsylvania have reported that magnetic resonance imaging (MRI) is superior to digital mammography or ultrasound for the detection of breast cancer in high-risk women. The details of this study appeared in an early online publication in the Journal of Clinical Oncology on November 2, 2009.jmaxon@onco-ed.com (jenny maxon)Fri, 20 Nov 2009 11:43:57 GMThttp://professional.cancerconsultants.com/news.aspx?id=44307http://professional.cancerconsultants.com/news.aspx?id=44307Researchers from Columbia Medical Center have reported that by 2002, 45.9% of Medicare recipients with common cancers were treated with erythropoiesis-stimulating agents (ESAs) such a Procrit® (epoetin alfa) and Aranesp® (darbepoietin). The details of this study appeared in an early online publication in the Journal of the National Cancer Institute on November 10, 2009.jmaxon@onco-ed.com (jenny maxon)Thu, 19 Nov 2009 11:20:26 GMThttp://professional.cancerconsultants.com/news.aspx?id=44306http://professional.cancerconsultants.com/news.aspx?id=44306Researchers from the National Cancer Institute and Dartmouth Medical School have reported that the risk of developing smoking-related bladder cancer has increased in New Hampshire over the risk observed in the 1990s. The details of this study appeared in the November 18, 2009 issue of the Journal of the National Cancer Institute.jmaxon@onco-ed.com (jenny maxon)Thu, 19 Nov 2009 11:04:37 GMThttp://professional.cancerconsultants.com/news.aspx?id=44305http://professional.cancerconsultants.com/news.aspx?id=44305Researchers from Norway have reported that folic acid and B12 supplements in patients with ischemic heart disease increase the risk of cancer and all-cause mortality. The details of this study appeared in the November 18, 2009 issue of the Journal of the American Medical Society.jmaxon@onco-ed.com (jenny maxon)Thu, 19 Nov 2009 10:49:22 GMThttp://professional.cancerconsultants.com/news.aspx?id=44302http://professional.cancerconsultants.com/news.aspx?id=44302Researchers from Columbia University have reported that induction and maintenance therapy with intravesical Taxotere® (docetaxel) is well tolerated and effective for treatment of patients with non-muscle-invasive bladder cancer who are refractory to Bacilli Calmette-Guerin (BCG) therapy. The details of this study were reported in the October 2009 issue of British Journal of Urology International.jmaxon@onco-ed.com (jenny maxon)Wed, 18 Nov 2009 16:05:34 GMThttp://professional.cancerconsultants.com/news.aspx?id=44301http://professional.cancerconsultants.com/news.aspx?id=44301Researchers from U.S. and European medical centers have reported that not sitting during work, occupational activity, walking, and biking can reduce the risk of developing prostate cancer. The details of this study were published early online on October 27, 2009 in the British Journal of Cancer.jmaxon@onco-ed.com (jenny maxon)Wed, 18 Nov 2009 15:59:42 GMThttp://professional.cancerconsultants.com/news.aspx?id=44295http://professional.cancerconsultants.com/news.aspx?id=44295Researchers involved in an international randomized trial have reported that pertuzumab may add to the activity of Gemzar® (gemcitabine) for the treatment of platinum-resistant ovarian cancer. The details of this study appeared in an early online publication in the Journal of Clinical Oncology on November 9, 2009. jmaxon@onco-ed.com (jenny maxon)Mon, 16 Nov 2009 14:30:57 GMThttp://professional.cancerconsultants.com/news.aspx?id=44300http://professional.cancerconsultants.com/news.aspx?id=44300The U.S. Preventive Services Task Force (USPSTF) has released new guidelines for breast cancer screening that increase the interval between screenings for most women. The details of these new guidelines were published in the November 17, 2009 issue of the Annals of Internal Medicine and received prominent first page review in the November 17, 2009 issue of the New York Times.jmaxon@onco-ed.com (jenny maxon)Tue, 17 Nov 2009 15:25:00 GMT